Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014.

Autor: Caini S; Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118-124, 3513, CR, Utrecht, The Netherlands. s.caini@nivel.nl., Spreeuwenberg P; Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118-124, 3513, CR, Utrecht, The Netherlands., Kusznierz GF; Instituto Nacional de Enfermedades Respiratorias 'Dr. Emilio Coni', Santa Fe, Argentina., Rudi JM; Instituto Nacional de Enfermedades Respiratorias 'Dr. Emilio Coni', Santa Fe, Argentina., Owen R; Vaccine Preventable Diseases Surveillance Section, Health Policy Protection branch, Office for Health Protection, Department of Health, Woden, Canberra, Australia., Pennington K; Vaccine Preventable Diseases Surveillance Section, Health Policy Protection branch, Office for Health Protection, Department of Health, Woden, Canberra, Australia., Wangchuk S; Public Health Laboratory, Department of Public Health, Ministry of Health, Thimphu, Bhutan., Gyeltshen S; Public Health Laboratory, Department of Public Health, Ministry of Health, Thimphu, Bhutan., Ferreira de Almeida WA; Ministry of Health, Brasilia, DF, Brazil., Pessanha Henriques CM; Ministry of Health, Brasilia, DF, Brazil., Njouom R; Virology Department, Centre Pasteur of Cameroon, Yaoundé, Cameroon., Vernet MA; Virology Department, Centre Pasteur of Cameroon, Yaoundé, Cameroon., Fasce RA; Sección Virus Respiratorios, Instituto de Salud Pública de Chile, Santiago, Chile., Andrade W; Sección Virus Respiratorios, Instituto de Salud Pública de Chile, Santiago, Chile., Yu H; Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China., Feng L; Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China., Yang J; Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China., Peng Z; Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China., Lara J; National Influenza Center, Ministry of Health, San José, Costa Rica., Bruno A; Instituto Nacional de Investigacion en Salud Publica (INSPI), Centro de Referencia Nacional de Influenza y otros Virus Respiratorios, Guayaquil, Ecuador., de Mora D; Instituto Nacional de Investigacion en Salud Publica (INSPI), Centro de Referencia Nacional de Influenza y otros Virus Respiratorios, Guayaquil, Ecuador., de Lozano C; National Influenza Center, Ministry of Health, San Salvador, El Salvador., Zambon M; Respiratory Virus Unit, Public Health England, London, Colindale, UK., Pebody R; Respiratory Diseases Department, Public Health England, London, Colindale, UK., Castillo L; National Influenza Center, Ministry of Health, Guatemala City, Guatemala., Clara AW; US Centers for Disease Control, Central American Region, Guatemala City, Guatemala., Matute ML; National Influenza Center, Ministry of Health, Tegucigalpa, Honduras., Kosasih H; US Naval Medical Research Unit No.2, Jakarta, Indonesia., Nurhayati; US Naval Medical Research Unit No.2, Jakarta, Indonesia., Puzelli S; National Influenza Center, National Institute of Health, Rome, Italy., Rizzo C; National Center for Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome, Italy., Kadjo HA; Department of Epidemic Virus, Institut Pasteur, Abidjan, Côte d'Ivoire., Daouda C; Service of Epidemiological Diseases Surveillance, National Institute of Public Hygiene, Abidjan, Côte d'Ivoire., Kiyanbekova L; National Center of Expertise, Committee of Consumer Right Protection, Astana, Kazakhstan., Ospanova A; Zonal Virology Laboratory, National Center of Expertise, Committee of Consumer Right Protection, Astana, Kazakhstan., Mott JA; Centers for Disease Control and Prevention - Kenya Country Office, Nairobi, Kenya.; US Public Health Service, Rockville, Maryland, USA., Emukule GO; Centers for Disease Control and Prevention - Kenya Country Office, Nairobi, Kenya., Heraud JM; National Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo, Madagascar., Razanajatovo NH; National Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo, Madagascar., Barakat A; National Influenza Center, Institut National d'Hygiène, Ministry of Health, Rabat, Morocco., El Falaki F; National Influenza Center, Institut National d'Hygiène, Ministry of Health, Rabat, Morocco., Huang SQ; Institute of Environmental Science and Research, Wellington, New Zealand., Lopez L; Institute of Environmental Science and Research, Wellington, New Zealand., Balmaseda A; National Influenza Center, Ministry of Health, Managua, Nicaragua., Moreno B; National Influenza Center, IC Gorgas, Panama City, Panama., Rodrigues AP; Department of epidemiology, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal., Guiomar R; National Influenza Reference Laboratory, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal., Ang LW; Epidemiology and Disease Control Division, Ministry of Health, Singapore, Singapore., Lee VJM; Communicable Diseases Division, Ministry of Health, Singapore, Singapore., Venter M; Global Disease Detection, US-CDC, Pretoria, South Africa.; Zoonoses Research Center, Department of Medical Virology, University of Pretoria, Pretoria, South Africa., Cohen C; Centre for Respiratory Diseases and Meningitis (CRDM), National Institute for Communicable Diseases, Johannesburg, South Africa.; School of Public Health, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa., Badur S; Istanbul University, Istanbul, Turkey., Ciblak MA; Istanbul University, Istanbul, Turkey., Mironenko A; L.V.Gromashevsky Institute of Epidemiology and Infectious Diseases National Academy of Medical Science of Ukraine, Reiv, Ukraine., Holubka O; L.V.Gromashevsky Institute of Epidemiology and Infectious Diseases National Academy of Medical Science of Ukraine, Reiv, Ukraine., Bresee J; Epidemiology and Prevention Branch, Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA., Brammer L; Epidemiology and Prevention Branch, Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA., Hoang PVM; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam., Le MTQ; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam., Fleming D; Independent scientist, Birmingham, UK., Séblain CE; Sanofi Pasteur, Lyon, France., Schellevis F; Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118-124, 3513, CR, Utrecht, The Netherlands.; Department of General Practice & Elderly Care Medicine, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, the Netherlands., Paget J; Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118-124, 3513, CR, Utrecht, The Netherlands.
Jazyk: angličtina
Zdroj: BMC infectious diseases [BMC Infect Dis] 2018 Jun 08; Vol. 18 (1), pp. 269. Date of Electronic Publication: 2018 Jun 08.
DOI: 10.1186/s12879-018-3181-y
Abstrakt: Background: Influenza disease burden varies by age and this has important public health implications. We compared the proportional distribution of different influenza virus types within age strata using surveillance data from twenty-nine countries during 1999-2014 (N=358,796 influenza cases).
Methods: For each virus, we calculated a Relative Illness Ratio (defined as the ratio of the percentage of cases in an age group to the percentage of the country population in the same age group) for young children (0-4 years), older children (5-17 years), young adults (18-39 years), older adults (40-64 years), and the elderly (65+ years). We used random-effects meta-analysis models to obtain summary relative illness ratios (sRIRs), and conducted meta-regression and sub-group analyses to explore causes of between-estimates heterogeneity.
Results: The influenza virus with highest sRIR was A(H1N1) for young children, B for older children, A(H1N1)pdm2009 for adults, and (A(H3N2) for the elderly. As expected, considering the diverse nature of the national surveillance datasets included in our analysis, between-estimates heterogeneity was high (I 2 >90%) for most sRIRs. The variations of countries' geographic, demographic and economic characteristics and the proportion of outpatients among reported influenza cases explained only part of the heterogeneity, suggesting that multiple factors were at play.
Conclusions: These results highlight the importance of presenting burden of disease estimates by age group and virus (sub)type.
Databáze: MEDLINE
Externí odkaz: